DRREDDY's weekly performance was strong, with a 2.96% return, outperforming peers SUNPHARMA and DIVISLAB, but slightly underperforming HINDUNILVR. The stock's volatility was moderate at 13.31%, lower than DIVISLAB's but higher than HINDUNILVR's. The Sharpe Ratio of 0.88 indicates a relatively attractive risk-return profile. Overall, DRREDDY's performance was robust, with a low Max Drawdown of -0.07%, suggesting a relatively low-risk week.

[Volatility: 13.31%]